½ÃÀ庸°í¼­
»óǰÄÚµå
1568979

¼¼°èÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2031³â)

Brain Computer Interface Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 167 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°è ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º(BCI) ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼­¸¦ ¹ßÇàÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ¼ºÀå ÃËÁø¿äÀÎ, ½ÃÀå µ¿Çâ, ÃËÁø¿äÀÎ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇÐÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© ½ÃÀåÀÇ ÇöÀç ±¸Á¶¿Í ¹Ì·¡¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå ±Ô¸ð(2024³â) : 2¾ï 5,770¸¸ ´Þ·¯
  • ¿¹Ãø ½ÃÀå ±Ô¸ð(2031³â) : 7¾ï 1,300¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â±îÁö) : 13.8%

ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå - Á¶»ç ¹üÀ§:

ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀº Àΰ£ÀÇ ³ú¿Í ¿ÜºÎ Àåºñ °£ÀÇ Á÷Á¢ Åë½ÅÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ½Ã½ºÅÛÀÇ °³Ã´À» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ³ú ½ÅÈ£¸¦ ÇØ¼®ÇÏ¿© ÄÄÇ»ÅÍ, ÀÇÁö Àåºñ, º¸Á¶ Àåºñ µîÀÇ ¿ÜºÎ ¾ÖÇø®ÄÉÀ̼ÇÀÇ Á¦¾î¸¦ ¿ëÀÌÇϰÔÇÏ°í ½Å°æ Áúȯ°ú Àå¾Ö°¡ÀÖ´Â »ç¶÷µéÀ» µ½½À´Ï´Ù. BCI´Â ¹°¸®Àû Á¢ÃË ¾øÀÌ Àåºñ¸¦ Á¦¾îÇϱâ À§ÇØ ÀÇ·á, °ÔÀÓ, ÀÚµ¿Â÷ µîÀÇ ºÎ¹®¿¡¼­ Á¡Á¡ ´õ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ȯÀÚÀÇ QOL Çâ»ó¿¡ ´ëÇÑ °ü½É Áõ°¡, ½Å°æ ±â¼úÀÇ Áøº¸, BCI ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡°¡ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. BCI ½ÃÀå¿¡´Â ´Ù¾çÇÑ ÀÎÅÍÆäÀ̽º À¯Çü, ½ÅÈ£ ȹµæ ¹æ¹ý, ´Ù¾çÇÑ ºÎ¹®¿¡ ´ëÇÑ ÀÀ¿ëÀÌ Æ÷ÇԵ˴ϴÙ.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¸î °¡Áö ¿äÀÎÀÌ ¼¼°è ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÆÄŲ½¼º´, °£Áú, ³úÁ¹Áß µî ½Å°æÁúȯÀÇ À¯º´·ü »ó½ÂÀ¸·Î ȯÀÚÀÇ ÀÇ»ç¼ÒÅë°ú À̵¿À» Áö¿øÇÏ´Â Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½Å°æ À̹Ì¡°ú ½ÅÈ£ ó¸® ±â¼úÀÇ Áøº¸·Î BCIÀÇ Á¤È®¼º°ú ±â´É¼ºÀÌ Çâ»óµÇ¾î º¸´Ù Æø³ÐÀº ÀÇ·á ¿ëµµ·Î ÀÌ¿ëÇϱ⠽¬¿öÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ AI¿Í ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀº ³ú ½ÅÈ£ 󸮸¦ °­È­ÇÏ°í º¸´Ù ¹ÝÀÀ¼ºÀÌ ³ô°í È¿À²ÀûÀÎ BCI ½Ã½ºÅÛÀ» ½ÇÇöÇϰí ÀÖ½À´Ï´Ù. ¸ôÀÔÇü üÇèÀ» À§ÇÑ °ÔÀÓ ¹× ¿£ÅÍÅ×ÀÎ¸ÕÆ® »ê¾÷, ¿îÀü Áö¿ø ½Ã½ºÅÛÀ» À§ÇÑ ÀÚµ¿Â÷ ºÎ¹®¿¡¼­ÀÇ BCI ÀÌ¿ë Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

±× À¯¸ÁÇÑ Àü¸Á¿¡µµ ºÒ±¸Çϰí, ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀº ÀÏÁ¤ÇÑ ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. BCI ½Ã½ºÅÛÀÇ °³¹ß ¹× µµÀÔ¿¡ µû¸¥ °íºñ¿ëÀº ƯÈ÷ °³¹ß µµ»ó Áö¿ª¿¡¼­ÀÇ Ã¤¿ëÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. BCI´Â ³ú ½ÅÈ£¿ÍÀÇ Á÷Á¢ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ¼ö¹ÝÇϱ⠶§¹®¿¡ ½Å°æ µ¥ÀÌÅÍÀÇ ÇÁ¶óÀ̹ö½Ã¿Í º¸¾È¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á°¡ Å®´Ï´Ù. ¶ÇÇÑ ÀÇ·á µî±Þ BCI¿¡ ´ëÇÑ ±ÔÁ¦ Àå¾Ö¹°°ú BCI °³¹ßÀ» À§ÇÑ Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄÝÀÇ ºÎÁ·Àº ½ÃÀå ¼ºÀå ¼Óµµ¸¦ ´ÊÃâ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀϺΠ¾ÖÇø®ÄÉÀ̼ÇÀº ½ÅÈ£ °£¼· ¹× ħ½ÀÀû Á¶Ä¡ÀÇ Çʿ伺°ú °°Àº ±â¼úÀû ÇѰ踦 °¡Áö¸ç BCIÀÇ È®»êÀ» Á¦ÇÑ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀº ´Ù¾çÇÑ »ê¾÷ ºÎ¹®¿¡¼­ÀÇ Àû¿ë ¹üÀ§¸¦ È®´ëÇÔÀ¸·Î½á Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Àå¾ÖÀÎÀ» À§ÇÑ Áö¿ø ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â BCI °³¹ßÀ» À§ÇÑ ºñ¿ÁÇÑ Åä¾çÀ» ¼³¸íÇÕ´Ï´Ù. ºñħ½ÀÀû BCI¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸´Â ½º¸¶Æ® Ȩ Á¦¾î ¹× ¿þ¾î·¯ºí ±â¼ú°ú °°Àº ÀÏ»óÀûÀÎ ¿ëµµ¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â º¸´Ù ¾ÈÀüÇϰí Á¢±Ù °¡´ÉÇÑ ½Ã½ºÅÛÀÇ °¡´É¼ºÀ» ¼³¸íÇÕ´Ï´Ù. ¶ÇÇÑ °ÔÀÓ ¹× ¿£ÅÍÅ×ÀÎ¸ÕÆ® »ê¾÷µµ Áß¿äÇÑ ±âȸ ºÎ¹®À̸ç, BCI°¡ »ç¿ëÀÚÀÇ °¡»ó ȯ°æ°úÀÇ °ü°è¿¡ Çõ¸íÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÇÏÀÌÅ×Å© ±â¾÷°ú ÀÇ·á Á¦°ø¾÷üÀÇ ÆÄÆ®³Ê½ÊÀº ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇÑ Çõ½ÅÀûÀÎ BCI ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ÃËÁøÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀº BCIÀÇ ¹Ì·¡¸¦ ¾î¶»°Ô Çü¼ºÇϴ°¡?
  • ºñÀÇ·á¿ë BCI ¿ëµµÀÇ È®´ë¿¡ À־ÀÇ ÁÖ¿ä °úÁ¦´Â?
  • BCI ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ±â¾÷Àº ´©±¸ÀÌ¸ç °æÀïÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú ¹Ì·¡´Â?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ¼½Åͺ° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ÀÇ·á IT ÁöÃâ Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡°¡ ÀÖ´Â ÅëÂû

  • Á¦Ç° ä¿ë ºÐ¼®
  • ±â¼úÆò°¡
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå °¡°Ý ºÐ¼®, 2024A

  • Á¦Ç° °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
  • ÄÄÆ÷³ÍÆ®º° °¡°Ý ºÐ¼®
  • Áö¿ªº° °¡°Ý°ú Á¦Ç° ÃëÇâ

Á¦5Àå ¼¼°èÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

    • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ë ±Ý¾× ±âȸ
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
  • ¼¼°èÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ÄÄÆ÷³ÍÆ®
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, ÄÄÆ÷³ÍÆ®º°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
      • Çϵå¿þ¾î
      • ¼ÒÇÁÆ®¿þ¾î
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÄÄÆ÷³ÍÆ®
  • ¼¼°è ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: Á¦Ç°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, Á¦Ç°º°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
      • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
      • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
      • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ±â¼ú
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, ±â¼úº°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
      • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
      • ÇÇÁú Àü±â ±â·Ï(ECoG)
      • ³úÆÄ ½ÃÇè(EEG)
      • ³úÀÚµµ ½ÃÇè(MEG)
      • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ±â¼ú
  • ¼¼°è ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á : ÃÖÁ¾ »ç¿ëÀÚ
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, ÃÖÁ¾ »ç¿ëÀÚº°, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
      • º´¿ø ¹× Ŭ¸®´Ð
      • ÀçÅÃÄ¡·á
      • ÀçȰ¼¾ÅÍ
      • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚ

Á¦6Àå ¼¼°èÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á : Áö¿ª

  • 2019-2023³â¿¡ À־ÀÇ Áö¿ªº° ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ °ú°Å ºÐ¼®
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Áö¿ªº°, 2024-2033³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® :Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ½ÇÀû ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2033³â
    • ¹Ì±¹
    • ij³ª´Ù
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
    • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
    • ÇÇÁú Àü±â ±â·Ï(ECoG)
    • ³úÆÄ ½ÃÇè(EEG)
    • ³úÀÚµµ ½ÃÇè(MEG)
    • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • ÀçÅÃÄ¡·á
    • ÀçȰ¼¾ÅÍ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦8Àå À¯·´ÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ½ÇÀû ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2033³â
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ÅÍŰ
    • ±âŸ À¯·´
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
    • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
    • ÇÇÁú Àü±â ±â·Ï(ECoG)
    • ³úÆÄ ½ÃÇè(EEG)
    • ³úÀÚµµ ½ÃÇè(MEG)
    • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • ÀçÅÃÄ¡·á
    • ÀçȰ¼¾ÅÍ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ½ÇÀû ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2033³â
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
    • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
    • ÇÇÁú Àü±â ±â·Ï(ECoG)
    • ³úÆÄ ½ÃÇè(EEG)
    • ³úÀÚµµ ½ÃÇè(MEG)
    • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • ÀçÅÃÄ¡·á
    • ÀçȰ¼¾ÅÍ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦10Àå ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾ÆÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ½ÇÀû ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2033³â
    • Àεµ
    • µ¿³²¾Æ½Ã¾Æ
    • È£ÁÖ
    • ±âŸ ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
    • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
    • ÇÇÁú Àü±â ±â·Ï(ECoG)
    • ³úÆÄ ½ÃÇè(EEG)
    • ³úÀÚµµ ½ÃÇè(MEG)
    • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • ÀçÅÃÄ¡·á
    • ÀçȰ¼¾ÅÍ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ½ÇÀû ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2033³â
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
    • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
    • ÇÇÁú Àü±â ±â·Ï(ECoG)
    • ³úÆÄ ½ÃÇè(EEG)
    • ³úÀÚµµ ½ÃÇè(MEG)
    • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • ÀçÅÃÄ¡·á
    • ÀçȰ¼¾ÅÍ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º ½ÃÀå Àü¸Á: ½ÇÀû(2019-2023³â)°ú ¿¹Ãø(2024-2033³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ½ÇÀû ºÐ¼®, ½ÃÀ庰, 2019-2023³â
    • ±¹°¡º°
    • ÄÄÆ÷³ÍÆ®º°
    • Á¦Ç°º°
    • ÃÖÁ¾ »ç¿ëÀÚº°
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±¹°¡º°, 2024-2033³â
    • GCC ±¹°¡
    • ÀÌÁýÆ®
    • ³²¾ÆÇÁ¸®Ä«
    • ºÏ¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÄÄÆ÷³ÍÆ®º°, 2024-2033³â
    • Çϵå¿þ¾î
    • ¼ÒÇÁÆ®¿þ¾î
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, Á¦Ç°º°, 2024-2033³â
    • ħ½ÀÀû ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºñħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
    • ºÎºÐ ħ½À¼º ºê·¹ÀÎ ÄÄÇ»ÅÍ ÀÎÅÍÆäÀ̽º
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, ±â¼úº°, 2024-2033³â
    • ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó¹ý(fMRI)
    • ÇÇÁú Àü±â ±â·Ï(ECoG)
    • ³úÆÄ ½ÃÇè(EEG)
    • ³úÀÚµµ ½ÃÇè(MEG)
    • ±â´ÉÀû ±ÙÀû¿Ü¼± ºÐ±¤¹ý(fNRI)
  • ÇöÀç ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, ÃÖÁ¾ »ç¿ëÀÚº°, 2024-2033³â
    • º´¿ø ¹× Ŭ¸®´Ð
    • ÀçÅÃÄ¡·á
    • ÀçȰ¼¾ÅÍ
    • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °­µµ ¸ÅÇÎ
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • ANT Neuro
    • MindMaze
    • Cortec GmbH
    • BirgerMind
    • Conscious Labs
    • Paradromics
    • Advanced Brain Monitoring, Inc.
    • Bitbrain
    • Kernel
    • BrainCo
    • Blackrock Neurotech
    • Emotiv
    • Neurosky
    • Brain Products GmbH
    • Ripple Neuro
    • CGX
    • Nexstem
    • Artinis Medical Systems
    • Onward Medical NV
    • Neurable
    • Neurolutions, Inc.
    • Open BCI
    • InBrain Neuroelectronics SL

Á¦14Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦
  • µÎÀÚ¾î ¹× ¾à¾î
JHS 24.10.24

Persistence Market Research has recently published a comprehensive report on the global Brain Computer Interface (BCI) Market. This report provides an in-depth analysis of key market dynamics, including growth drivers, market trends, opportunities, and challenges, offering valuable insights into the market's current structure and future potential.

Key Insights:

  • Brain Computer Interface Market Size (2024E): US$257.7 Mn
  • Projected Market Value (2031F): US$713.0 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.8%

Brain Computer Interface Market - Report Scope:

The Brain Computer Interface Market involves the development of systems that enable direct communication between the human brain and external devices. These systems interpret brain signals to facilitate control of external applications, such as computers, prosthetics, and assistive devices, thereby aiding individuals with neurological conditions or disabilities. BCIs are increasingly utilized in medical, gaming, and automotive applications for controlling devices without physical contact. The growing focus on enhancing patient quality of life, advancements in neurotechnology, and rising investments in BCI research are driving market expansion. The scope of the BCI market includes various interface types, signal acquisition methods, and applications across diverse sectors.

Market Growth Drivers:

Several factors are propelling the global Brain Computer Interface Market. The rising prevalence of neurological disorders, such as Parkinson's disease, epilepsy, and strokes, has created a demand for innovative solutions that can assist patients in communication and mobility. Advances in neuroimaging and signal processing technologies are improving the accuracy and functionality of BCIs, making them more accessible for a broader range of medical applications. Furthermore, the integration of AI and machine learning algorithms is enhancing the processing of brain signals, leading to more responsive and efficient BCI systems. The increasing use of BCIs in the gaming and entertainment industry for immersive experiences, as well as in the automotive sector for driver assistance systems, also supports market growth.

Market Restraints:

Despite its promising outlook, the Brain Computer Interface Market faces certain challenges. High costs associated with the development and implementation of BCI systems may limit their adoption, particularly in developing regions. Ethical concerns regarding the privacy and security of neural data are significant, as BCIs involve direct interaction with brain signals. Moreover, regulatory hurdles for medical-grade BCIs, as well as the lack of standardized protocols for BCI development, may slow down the pace of market growth. There are also technical limitations, such as signal interference and the need for invasive procedures in some applications, which could restrict the widespread use of BCIs.

Market Opportunities:

The Brain Computer Interface Market presents significant growth opportunities, driven by the expanding application scope across various industries. The increasing demand for assistive technologies for people with disabilities provides a fertile ground for BCI development. Ongoing research into non-invasive BCIs offers potential for safer and more accessible systems that can be used in everyday applications, such as smart home control and wearable technology. The gaming and entertainment industry is also a key opportunity area, with the potential for BCIs to revolutionize the way users interact with virtual environments. Additionally, partnerships between tech companies and healthcare providers are likely to foster the development of innovative BCI solutions aimed at improving patient outcomes.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Brain Computer Interface Market globally?
  • How is the integration of AI and machine learning shaping the future of BCIs?
  • What are the key challenges in scaling BCI applications for non-medical use cases?
  • Who are the major players in the BCI market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects for the Brain Computer Interface Market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Brain Computer Interface Market, including Neuralink Corporation, Emotiv Inc., and NeuroSky Inc., are focusing on technological advancements, product innovation, and strategic collaborations to gain a competitive advantage. These companies invest significantly in R&D to develop advanced BCI systems that cater to various applications, from medical rehabilitation to consumer electronics. Collaborations with academic institutions and healthcare providers help to validate new technologies and expand market reach. Emphasis on regulatory compliance, safety standards, and data privacy measures further enhances the credibility and adoption of BCI technologies.

Key Companies Profiled:

  • ANT Neuro
  • MindMaze
  • Cortec GmbH
  • BirgerMind
  • Conscious Labs
  • Paradromics
  • Advanced Brain Monitoring, Inc.
  • Bitbrain
  • Kernel

Brain Computer Interface Market Industry Segmentation

By Component

  • Hardware
  • Software

By Product

  • Invasive Brain Computer Interface
  • Non-invasive Brain Computer Interface
  • Partially Invasive Brain Computer Interface

By Technology

  • Functional Magnetic Resonance Imaging (fMRI)
  • Electrocorticography (ECoG)
  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Functional Near-Infrared Spectroscopy (fNRIs)

By End User

  • Hospitals & Clinics
  • Homecare Settings
  • Rehabilitation Centers
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Brain Computer Interface Market Snapshot, 2024-2033
  • 1.2. Market Opportunity Assessment, 2024-2033, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare IT Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Component
  • 4.4. Regional Prices and Product Preferences

5. Global Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 5.1. Key Highlights
    • 5.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.2. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2033
  • 5.3. Global Brain Computer Interface Market Outlook: Component
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis, By Component, 2019-2023
    • 5.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
      • 5.3.3.1. Hardware
      • 5.3.3.2. Software
  • 5.4. Market Attractiveness Analysis: Component
  • 5.5. Global Brain Computer Interface Market Outlook: Product
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
      • 5.5.3.1. Invasive Brain Computer Interface
      • 5.5.3.2. Non-invasive Brain Computer Interface
      • 5.5.3.3. Partially Invasive Brain Computer Interface
  • 5.6. Market Attractiveness Analysis: Product
  • 5.7. Global Brain Computer Interface Market Outlook: Technology
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2023
    • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
      • 5.7.3.1. Functional Magnetic Resonance Imaging (fMRI)
      • 5.7.3.2. Electrocorticography (ECoG)
      • 5.7.3.3. Electroencephalography (EEG)
      • 5.7.3.4. Magnetoencephalography (MEG)
      • 5.7.3.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 5.8. Market Attractiveness Analysis: Technology
  • 5.9. Global Brain Computer Interface Market Outlook: End User
    • 5.9.1. Introduction / Key Findings
    • 5.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
    • 5.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
      • 5.9.3.1. Hospitals & Clinics
      • 5.9.3.2. Homecare Settings
      • 5.9.3.3. Rehabilitation Centers
      • 5.9.3.4. Others
  • 5.10. Market Attractiveness Analysis: End User

6. Global Brain Computer Interface Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2033
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Component
    • 7.2.3. By Product
    • 7.2.4. By Technology
    • 7.2.5. By End User
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
    • 7.4.1. Hardware
    • 7.4.2. Software
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 7.5.1. Invasive Brain Computer Interface
    • 7.5.2. Non-invasive Brain Computer Interface
    • 7.5.3. Partially Invasive Brain Computer Interface
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 7.6.1. Functional Magnetic Resonance Imaging (fMRI)
    • 7.6.2. Electrocorticography (ECoG)
    • 7.6.3. Electroencephalography (EEG)
    • 7.6.4. Magnetoencephalography (MEG)
    • 7.6.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 7.7.1. Hospitals & Clinics
    • 7.7.2. Homecare Settings
    • 7.7.3. Rehabilitation Centers
    • 7.7.4. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Component
    • 8.2.3. By Product
    • 8.2.4. By Technology
    • 8.2.5. By End User
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkiye
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
    • 8.4.1. Hardware
    • 8.4.2. Software
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 8.5.1. Invasive Brain Computer Interface
    • 8.5.2. Non-invasive Brain Computer Interface
    • 8.5.3. Partially Invasive Brain Computer Interface
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 8.6.1. Functional Magnetic Resonance Imaging (fMRI)
    • 8.6.2. Electrocorticography (ECoG)
    • 8.6.3. Electroencephalography (EEG)
    • 8.6.4. Magnetoencephalography (MEG)
    • 8.6.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 8.7.1. Hospitals & Clinics
    • 8.7.2. Homecare Settings
    • 8.7.3. Rehabilitation Centers
    • 8.7.4. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Component
    • 9.2.3. By Product
    • 9.2.4. By Technology
    • 9.2.5. By End User
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
    • 9.4.1. Hardware
    • 9.4.2. Software
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 9.5.1. Invasive Brain Computer Interface
    • 9.5.2. Non-invasive Brain Computer Interface
    • 9.5.3. Partially Invasive Brain Computer Interface
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 9.6.1. Functional Magnetic Resonance Imaging (fMRI)
    • 9.6.2. Electrocorticography (ECoG)
    • 9.6.3. Electroencephalography (EEG)
    • 9.6.4. Magnetoencephalography (MEG)
    • 9.6.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 9.7.1. Hospitals & Clinics
    • 9.7.2. Homecare Settings
    • 9.7.3. Rehabilitation Centers
    • 9.7.4. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Component
    • 10.2.3. By Product
    • 10.2.4. By Technology
    • 10.2.5. By End User
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
    • 10.4.1. Hardware
    • 10.4.2. Software
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 10.5.1. Invasive Brain Computer Interface
    • 10.5.2. Non-invasive Brain Computer Interface
    • 10.5.3. Partially Invasive Brain Computer Interface
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 10.6.1. Functional Magnetic Resonance Imaging (fMRI)
    • 10.6.2. Electrocorticography (ECoG)
    • 10.6.3. Electroencephalography (EEG)
    • 10.6.4. Magnetoencephalography (MEG)
    • 10.6.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 10.7.1. Hospitals & Clinics
    • 10.7.2. Homecare Settings
    • 10.7.3. Rehabilitation Centers
    • 10.7.4. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Component
    • 11.2.3. By Product
    • 11.2.4. By Technology
    • 11.2.5. By End User
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
    • 11.4.1. Hardware
    • 11.4.2. Software
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 11.5.1. Invasive Brain Computer Interface
    • 11.5.2. Non-invasive Brain Computer Interface
    • 11.5.3. Partially Invasive Brain Computer Interface
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 11.6.1. Functional Magnetic Resonance Imaging (fMRI)
    • 11.6.2. Electrocorticography (ECoG)
    • 11.6.3. Electroencephalography (EEG)
    • 11.6.4. Magnetoencephalography (MEG)
    • 11.6.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 11.7.1. Hospitals & Clinics
    • 11.7.2. Homecare Settings
    • 11.7.3. Rehabilitation Centers
    • 11.7.4. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Brain Computer Interface Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
    • 12.2.1. By Country
    • 12.2.2. By Component
    • 12.2.3. By Product
    • 12.2.4. By Technology
    • 12.2.5. By End User
  • 12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Mn) Analysis and Forecast, By Component, 2024-2033
    • 12.4.1. Hardware
    • 12.4.2. Software
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 12.5.1. Invasive Brain Computer Interface
    • 12.5.2. Non-invasive Brain Computer Interface
    • 12.5.3. Partially Invasive Brain Computer Interface
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 12.6.1. Functional Magnetic Resonance Imaging (fMRI)
    • 12.6.2. Electrocorticography (ECoG)
    • 12.6.3. Electroencephalography (EEG)
    • 12.6.4. Magnetoencephalography (MEG)
    • 12.6.5. Functional Near-Infrared Spectroscopy (fNRIs)
  • 12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 12.7.1. Hospitals & Clinics
    • 12.7.2. Homecare Settings
    • 12.7.3. Rehabilitation Centers
    • 12.7.4. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. ANT Neuro
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. MindMaze
      • 13.3.2.1. Overview
      • 13.3.2.2. Segments and Products
      • 13.3.2.3. Key Financials
      • 13.3.2.4. Market Developments
      • 13.3.2.5. Market Strategy
    • 13.3.3. Cortec GmbH
      • 13.3.3.1. Overview
      • 13.3.3.2. Segments and Products
      • 13.3.3.3. Key Financials
      • 13.3.3.4. Market Developments
      • 13.3.3.5. Market Strategy
    • 13.3.4. BirgerMind
      • 13.3.4.1. Overview
      • 13.3.4.2. Segments and Products
      • 13.3.4.3. Key Financials
      • 13.3.4.4. Market Developments
      • 13.3.4.5. Market Strategy
    • 13.3.5. Conscious Labs
      • 13.3.5.1.Overview
      • 13.3.5.2. Segments and Products
      • 13.3.5.3. Key Financials
      • 13.3.5.4. Market Developments
      • 13.3.5.5. Market Strategy
    • 13.3.6. Paradromics
      • 13.3.6.1. Overview
      • 13.3.6.2. Segments and Products
      • 13.3.6.3. Key Financials
      • 13.3.6.4. Market Developments
      • 13.3.6.5. Market Strategy
    • 13.3.7. Advanced Brain Monitoring, Inc.
      • 13.3.7.1. Overview
      • 13.3.7.2. Segments and Products
      • 13.3.7.3. Key Financials
      • 13.3.7.4. Market Developments
      • 13.3.7.5. Market Strategy
    • 13.3.8. Bitbrain
      • 13.3.8.1. Overview
      • 13.3.8.2. Segments and Products
      • 13.3.8.3. Key Financials
      • 13.3.8.4. Market Developments
      • 13.3.8.5. Market Strategy
    • 13.3.9. Kernel
      • 13.3.9.1. Overview
      • 13.3.9.2. Segments and Products
      • 13.3.9.3. Key Financials
      • 13.3.9.4. Market Developments
      • 13.3.9.5. Market Strategy
    • 13.3.10. BrainCo
      • 13.3.10.1. Overview
      • 13.3.10.2. Segments and Products
      • 13.3.10.3. Key Financials
      • 13.3.10.4. Market Developments
      • 13.3.10.5. Market Strategy
    • 13.3.19. Blackrock Neurotech
      • 13.3.19.1. Overview
      • 13.3.19.2. Segments and Products
      • 13.3.19.3. Key Financials
      • 13.3.19.4. Market Developments
      • 13.3.19.5. Market Strategy
    • 13.3.19. Emotiv
      • 13.3.19.1. Overview
      • 13.3.19.2. Segments and Products
      • 13.3.19.3. Key Financials
      • 13.3.19.4. Market Developments
      • 13.3.19.5. Market Strategy
    • 13.3.19. Neurosky
      • 13.3.19.1. Overview
      • 13.3.19.2. Segments and Products
      • 13.3.19.3. Key Financials
      • 13.3.19.4. Market Developments
      • 13.3.19.5. Market Strategy
    • 13.3.14. Brain Products GmbH
      • 13.3.14.1. Overview
      • 13.3.14.2. Segments and Products
      • 13.3.14.3. Key Financials
      • 13.3.14.4. Market Developments
      • 13.3.14.5. Market Strategy
    • 13.3.14. Ripple Neuro
      • 13.3.14.1. Overview
      • 13.3.14.2. Segments and Products
      • 13.3.14.3. Key Financials
      • 13.3.14.4. Market Developments
      • 13.3.14.5. Market Strategy
    • 13.3.16. CGX
      • 13.3.16.1. Overview
      • 13.3.16.2. Segments and Products
      • 13.3.16.3. Key Financials
      • 13.3.16.4. Market Developments
      • 13.3.16.5. Market Strategy
    • 13.3.17. Nexstem
      • 13.3.17.1. Overview
      • 13.3.17.2. Segments and Products
      • 13.3.17.3. Key Financials
      • 13.3.17.4. Market Developments
      • 13.3.17.5. Market Strategy
    • 13.3.19. Artinis Medical Systems
      • 13.3.19.1. Overview
      • 13.3.19.2. Segments and Products
      • 13.3.19.3. Key Financials
      • 13.3.19.4. Market Developments
      • 13.3.19.5. Market Strategy
    • 13.3.19. Onward Medical N.V.
      • 13.3.19.1. Overview
      • 13.3.19.2. Segments and Products
      • 13.3.19.3. Key Financials
      • 13.3.19.4. Market Developments
      • 13.3.19.5. Market Strategy
    • 13.3.20. Neurable
      • 13.3.20.1. Overview
      • 13.3.20.2. Segments and Products
      • 13.3.20.3. Key Financials
      • 13.3.20.4. Market Developments
      • 13.3.20.5. Market Strategy
    • 13.3.21. Neurolutions, Inc.
      • 13.3.21.1. Overview
      • 13.3.21.2. Segments and Products
      • 13.3.21.3. Key Financials
      • 13.3.21.4. Market Developments
      • 13.3.21.5. Market Strategy
    • 13.3.22. Open BCI
      • 13.3.22.1. Overview
      • 13.3.22.2. Segments and Products
      • 13.3.22.3. Key Financials
      • 13.3.22.4. Market Developments
      • 13.3.22.5. Market Strategy
    • 13.3.23. InBrain Neuroelectronics S.L.
      • 13.3.23.1.Overview
      • 13.3.23.2. Segments and Products
      • 13.3.23.3. Key Financials
      • 13.3.23.4. Market Developments
      • 13.3.23.5. Market Strategy

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦